Oklo test reactor reaches criticality, while commercial power remains unlicensed

What happened

Oklo's Groves Isotope Test Reactor reached a sustained nuclear chain reaction near Austin, Canary Media reports. The low-power facility is designed to demonstrate medical-isotope production and is one of several projects in the Department of Energy's reactor pilot program; it is not one of Oklo's proposed 75-megawatt commercial power reactors.

Why it matters

Advanced reactors could eventually provide firm low-carbon electricity, but a laboratory criticality milestone is different from licensing, building, and operating a commercial power plant. Clear distinctions help the public evaluate progress without treating an early technical demonstration as proof of near-term grid deployment.

What to watch

• Whether the test reactor completes its isotope-production demonstrations safely and as planned.
• The Nuclear Regulatory Commission's review of Oklo's future commercial reactor applications.
• Verified cost, construction, fuel-supply, waste, and operating data from larger projects.

Sources & evidence

• Nuclear startup Oklo splits its first atoms in test reactorCanary Media report published August 6, 2026, distinguishing Oklo's low-power isotope test reactor from its proposed commercial power reactors.

Topics

• Advanced Nuclear
• Reactor Pilot Program
• Medical Isotopes
• Licensing
• Clean Energy